Credo Health, a Denver, CO-based company which specializes in technology for value-based care, raised $5.25M in Seed funding.
The round was led by FCA Venture Partners with existing investors including Hannah Grey VC, FirstMile Ventures, and Springtime Ventures.
The company intends to use the funds to further strengthen its technological infrastructure, expand its sales team, and continue driving innovation within the value based care market.
Led by Founder and CEO Carm Huntress, Credo Health provides a PreDx product that offers a pre-encounter risk analysis, clinical summaries and HEDIS Gap Closure through an AI-enabled analysis of digital medical records, allowing healthcare providers to make more informed clinical decisions and deliver more personalized care. Credo Health combines both digital and manual medical record retrieval with AI-driven analysis and human expertise to ensure providers have the complete clinical picture of every patient.